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Investigations of the effects of antidepressant treatment for individuals with major depression have
focused on short-term outcomes in individuals that meet very speciﬁc criteria; however, there is limited
knowledge about long-term outcomes associated with antidepressant use in general population samples.
This study aimed to investigate the long-term outcomes associated with antidepressant use by focusing
on 486 depressed adults in a prospective observational Canadian cohort in 1998/99. We used logistic
regression to investigate the association between antidepressant use and depression status 8 years later.
Non-random allocation to treatment was accounted for by a propensity-for-treatment model which
included thirteen predictors of antidepressant use, including: severity of depressive symptoms, previous
episodes of depression (from 1994 to 1997), physical health condition, social support and socio-demo-
graphic characteristics. 29% of individuals with major depression reported antidepressant use. After
adjusting for propensity for treatment in 1998/99, and antidepressant use from 2000 to 2007, depressed
individuals who reported antidepressant use in 1998/99 were less likely to be depressed in 2006/07
compared to those who did not report antidepressant use (OR ¼ 0.36, 95% CI: 0.15e0.88). Amongst
individuals with symptoms of major depression, those reporting use of anti-depressants at baseline
exhibited improved long-term outcomes in comparison to those who did not report treatment.
 2011 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
The use of antidepressant medications for the treatment of
depression has been rising steadily in recent years (Helgason et al.,
2004; Middleton et al., 2001; Patten and Beck, 2004), though the
majority of individuals with depression remain untreated (Colman
et al., 2008a, 2006; Patten and Beck, 2004). In the last thirty years,
an overwhelming number of randomized controlled trials have
demonstrated the efﬁcacy of antidepressant medications for the
treatment of depression (Fournier et al., 2010). However, these trials
have tended tohave relatively short follow-upperiods, oftenonly six
weeks (Barbui and Hotopf, 2001; Geddes et al., 2003). In addition,
these trials often have stringent criteria that exclude patients with
common comorbid symptoms or suicidal ideation, consequently
painting a picture of antidepressant efﬁcacy in unrealisticallyUniversity of Alberta, 3-50D
ta, Canada T6G 2T4. Tel.: þ1
).
Y-NC-ND license.homogeneous patient populations (Barbui and Hotopf, 2001; Leon
et al., 2003). There is a paucity of evidence regarding the long-
term effectiveness of antidepressant use (Rouillon, 2004).
Population-based samples, followed longitudinally, may be
helpful in clarifying whether the short-term efﬁcacy demonstrated
in clinical trials extends to long-term effectiveness, especially given
the low likelihood of long-term randomized controlled trials.
Observational studies, however, suffer from one crucial drawback
in comparison with randomized controlled trials: individuals who
receive treatment may differ in clinical or social factors from those
who do not, and these differences may affect prognosis, thereby
confounding any observed differences in outcome (D’Agostino,
1998). Naturalistic study designs must therefore be analyzed
using methods that can address these selection-to-treatment
elements, in order to estimate the actual impact of treatment that
would have been generated by a randomized design.
The propensity score approach is one method that can be used
for this purpose (Rosenbaum and Rubin, 1983). This method
reduces all of the covariates that might predict treatment into
a single score, which quantiﬁes the probability of being treated. If
two individuals have the same probability of being treated (i.e., the
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not, then it is as if they have been randomly assigned to treatment
(assuming that no unmeasured confounders exist) (D’Agostino,
1998; Rosenbaum and Rubin, 1983).
Using these methods, one recent study found that individuals in
mid-adulthood with severe symptoms of depression or anxiety who
reported antidepressantoranxiolyticusewere signiﬁcantly less likely
to suffer from the same symptoms ten years later (Colman et al.,
2008a); however, this ﬁnding has not been replicated. The primary
objective of this study was to investigate long-term outcomes asso-
ciated with self-reported antidepressant use on individuals with
major depression in a longitudinal cohort of adult Canadians.
2. Materials and methods
2.1. Sample
The National Population Health Survey (NPHS) is a nationwide
longitudinal study conducted by Statistics Canada, which started in
1994/95 and included health and other health-related information,
such as economic, social, demographic, occupational and environ-
mental data. At study inception, 17,276 individuals were randomly
selected using a stratiﬁed two-stage sample design. The cohort is
representative of the Canadian population, and has been followed-
up every two years. The ﬁrst cycle of interview in 1994/95 had
a response rate of 83.6%, while the follow-up rates of the third cycle
in 1998/99 and the most recent cycle in 2006/07 were 88.3% and
77.0%, respectively (Statistics Canada, 2007). The focus of this study
was 486 individuals aged 16 years or older who experienced
a major depressive episode in 1998/99, and had complete data
regarding factors associated with use of anti-depressants.
2.2. Depression status
Major depression in the NPHS is captured by the Composite
International Diagnostic Interview-Short Form (CIDI-SF). The CIDI-
SF, a 10-min interview, has been found to have 93% classiﬁcation
accuracy for a major depressive episode compared with the full
CIDI (Kessler et al., 1998), an hour-long interview that can identify
depressive episodes consistent with the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV) (American Psychiatric
Association, 1994). For each individual, the CIDI-SF produces
a predictive probability of a major depressive episode in the past 12
months (Kessler et al., 1998). An individual with a predictive
probability of 90% or higher was considered as having major
depression (a score of 5 or higher on a 0-8 scale) (Kessler et al.,
1998). This corresponds to DSM-IV criteria for a major depressive
episode: 5 of 9 depressive symptoms in a 2-week period during the
past year, including either loss of interest or depressed mood
(American Psychiatric Association, 1994).
2.3. Treatment of depression
The primary exposure of interest was self-reported use of anti-
depressants in 1998/99. In each cycle of the survey, survey
members were asked for information on prescription and over-the-
counter medications. With regards to antidepressant use, survey
members were asked “In the past month, did you take anti-
depressants such as Prozac, Paxil or Effexor?” (Statistics Canada,
1999) Individuals who responded positively to this question in
1998/99 were considered to be using anti-depressants. Self-report
of antidepressant use for depressed individuals has been estab-
lished as having high accuracy (Kwon et al., 2003).
A secondary exposure of interest was counseling by a health
professional (primarily physicians and psychologists). In 1998/99,survey members were asked whether they had seen a health
professional about their emotional or mental health in the previous
12 months. Individuals who responded positively to this question in
1998/99 were considered to be counseled by a health professional.
2.4. Confounding variables
Numerous factors are associated with both antidepressant
treatment and prognosis of depression. Notably, individuals with
more severe symptoms of depression are more likely to seek
treatment and to be treated with psychotropic medications
(Andrews et al., 2001; Burns et al., 2003; Colman et al., 2008b,
2006; Mojtabai et al., 2002; Spijker et al., 2001), and these indi-
viduals are also more likely to have a poorer prognosis (Kennedy
et al., 2003; Spijker et al., 2004). Similarly, individuals with
a history of depression or long-standing symptoms are more likely
to be treated (Spijker et al., 2001; Starkes et al., 2005; Colman et al.,
2008b, 2006), and are more likely to also have a poor prognosis
(Kennedy et al., 2003; Spijker et al., 2004; Mueller et al., 1999).
These factors confound the treatmenteoutcome relationship in
amanner such that it often appears that thosewho are treated have
a worse prognosis (i.e., confounding by indication). Consequently,
information was collected on several potential confounders.
Severity of symptoms was captured by including the CIDI-SF
score as well as a validated distress scale that includes feelings of
sadness, nervousness, restlessness, hopelessness, worthlessness
and feelings that “everything was an effort” over the preceding
month (Kessler et al., 2002).
History of depression was derived using data from the 1994/95
and 1996/97 cycles of the NPHS. Individuals who had major
depression at either of these time points according to the CIDI-SF
were considered to have a history of depression. The number of
weeks of depression an individual had experienced in the previous
year was also included in the propensity score.
In addition, suicidal behavior is associated with treatment-
seeking (Mojtabai et al., 2002; Burns et al., 2003; Colman et al.,
2008b; Starkes et al., 2005). NPHS respondents are asked about
any suicide attempts in the previous 12 months. Those who
responded positively in 1994/95, 1996/97, or 1998/99 were
considered to have a history of suicidal behavior.
Individuals in poor physical health are also more likely to seek
help during episodes of depression (Andrews et al., 2001; Colman
et al., 2008b; Mojtabai et al., 2002). Physical health was rated on
a 5-point scale in 1998/99; the presence of a chronic medical
condition was also reported (Statistics Canada, 1999).
Finally, several demographic features are associated with treat-
ment for depression, and may be related to prognosis; these were
included in the propensity score calculation. For example, those who
are female (Andrews et al., 2001; Mojtabai et al., 2002), divorced,
separated, or widowed (Andrews et al., 2001; Colman et al., 2008b;
Kisely et al., 2000; Mojtabai et al., 2002), unemployed (Colman et al.,
2008b; Kisely et al., 2000),more educated (Starkes et al., 2005), older
(Andrews et al., 2001; Kisely et al., 2000; Mojtabai et al., 2002), and
have less social support (Colman et al., 2008b; Mojtabai et al., 2002)
are more likely to be treated for depression.
2.5. Statistical analysis
We used propensity score techniques to account for non-
random allocation for treatment and subsequent confounding by
indication. The propensity score is the predicted probability of
antidepressant use, conditional on all available observed covariates
(Rubin, 1997). All potential confounders are included in a logistic
regression model to estimate the probability of antidepressant use
regardless of statistical signiﬁcance or multicollinearity. Since the
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(i.e., a propensity for treatment), redundant covariates do not harm
the model and over-parameterization is not a concern (Conniffe
et al., 2000). In addition, including all available potential
confounders ensures that the group that reports antidepressant use
and the group that does not are comparable.
The propensity score was computed based on all observations
with complete data in 1998/99 so that it wasmore representative of
the general population. The SURVEYLOGISTIC procedure was used
to predict the probability of reporting use of anti-depressants (i.e.,
propensity score) with incorporation of bootstrap weights (see
below). The individuals were grouped into 5 groups based on
propensity score quintiles. If no differences exist between cova-
riates within quintiles of the propensity score between the treated
and untreated group, then any overall differences in the covariates
can be considered “ignorable” in an analysis controlling for
propensity score quintiles (Rubin, 1997).
To distinguish possible long-term effects of antidepressant use
during the initial episode outside of its association with continuing
treatment, self-reported antidepressant use from 2000 to 2007was
also controlled in the model. An individual was considered to have
used anti-depressants recently if he/she had ever reported anti-
depressant use in 2000/01, 2002/03, 2004/05 or 2006/07.
The primary analysis used logistic regression to calculate the
association between reported antidepressant use in 1998/99 and
depression in 2006/07. Covariates in the model included the
propensity score and recent antidepressant use. The standard
errors for all estimates were calculated using the bootstrap method
(Rao and Wu, 1988). All estimates were weighted to adjust for
unequal selection probabilities and cluster sampling. Coefﬁcients of
variance (CVs) were calculated using the bootstrap method to
estimate the sample error.
The secondary analysis looked at antidepressant use in 1998/99
and depression in 2006/07, but used multinomial logistic regres-
sion to investigate outcomes associated with being in one of three
groups: (1) use of anti-depressants, (2) counseled by a health
professional but no antidepressant use, or (3) no treatment. For this
analysis we calculated a second propensity score for antidepressant
use or being counseled by a health professional using the same
confounding variables listed above.
SAS 9.2 was used for all analyses.Table 1
Factors associated with antidepressant use among 486 individuals with depression in 19
Variables measured in 1998/99
CIDI-SF depression score (mean)
Number of weeks depressed (mean)
Depression history (%) No previously reported episodes
One previously reported episode
Two previously reported episodes
Suicide attempt history (%)a Yes
Distress (mean)
Gender (%) Male
Age (mean)
Self-rated physical health (mean)
Social support (mean)
Chronic health condition (%) Yes
Marital Status (%) Divorced, Separated, Widowed
Education (%) Some post-secondary education
Employment Status (%) Employed
Unemployed
Not in Labor Force
*Statistically signiﬁcant at p < 0.05.
**Statistically signiﬁcant at p < 0.01.
a Results can not be shown due to conﬁdentiality.3. Results
The prevalence of major depression in 1998/99 among those
aged 16 or older was 4.5%. There were 486 individuals with
complete data to calculate the probability of antidepressant use.
Amongst these depressed individuals, 29.1% were using anti-
depressants. Another 26.5% reported being counseled by a health
professional.
Table 1 illustrates several differences between those who were
using anti-depressants and those who were not. Those who were
using anti-depressants had higher levels of distress, had been
depressed for longer, and were more likely to have a history of
depression. In addition, they were more likely to be female, in
poorer physical health, not employed, and to be divorced, separated
or widowed. A history of suicide attempts was included in the
propensity calculation; however, suicide attempts were rare.
Statistics Canada prohibits reporting small numbers in order to
protect conﬁdentiality, so these numbers are therefore not reported
explicitly.
All 13 variables listed in Table 1 were included in a logistic
regressionmodel that calculated propensity for antidepressant use.
Themodel explained 27% of the variation in antidepressant use. The
individuals were grouped into quintiles of the propensity score; all
covariates were balanced within each quintile between those using
anti-depressants and those not.
Of the 486 individuals with a major depressive episode, the
depression status of 321 individuals was followed-up eight years
later in 2006/07 (66%). Follow-up among those who reported
antidepressant use at baseline was 62%; 68% of those who did
who did not report antidepressant use at baseline were
successfully followed. 61.7% of the non-response was attribut-
able to loss to follow up, while 15.9% of the non-response
resulted from deceased individuals and institutionalized indi-
viduals, and another 22.4% of the respondents did not provide
complete depressive symptom information. Table 2 compares
those with follow-up information to those without. Individuals
who did not have follow-up data did not differ from those with
complete data with respect to CIDI-SF score or antidepressant
use in 1998/99. However, those who did not complete follow-up
had a longer duration of symptoms and a higher severity on the
distress scale in 1998/99.98/99.
Antidepressant use in 1998/99 p-value
Yes (29.1%) No (70.9%)
6.6 6.1 <0.01 **
18.7 10.8 <0.01 **
43.5 70.6 <0.01 **
30.3 21.4
26.3 8.0
0.96
10.9 8.2 <0.01 **
22.1 37.4 0.01 *
41.9 38.7 0.13
1.8 2.3 <0.01 **
3.8 3.9 0.31
85.0 77.0 0.08
35.3 20.8 <0.01 **
72.2 67.1 0.4
37.9 62.2 <0.01 **
4.0 4.4
58.1 33.3
Table 2
Comparison of those with outcome data at eight-year follow-up to those without outcome data among 486 individuals with depression in 1998/99.
Variables measured in 1998/99 Depression status measured in 2006/07 p-value
Complete data (66%) Incomplete data (34%)
CIDI-SF depression score (mean) 6.2 6.4 0.34
Antidepressant use (%) 27.2 32.5 0.34
Number of weeks depressed (mean) 11.4 16.3 0.01 *
Depression history (%) No previously reported episodes 63.2 61.8 0.73
One previously reported episode 24.6 22.8
Two previously reported episodes 12.2 15.4
Suicide attempt history (%) y Yes 0.18
Distress (mean) 8.3 10.3 <0.01 **
Gender (%) Male 32.3 34.2 0.75
Age (mean) 38.6 41.5 0.19
Self-rated physical health (mean) 2.3 1.9 <0.01 **
Social support (mean) 4.0 3.8 0.04 *
Chronic health condition (%) Yes 76.6 84.4 0.10
Marital Status (%) Divorced, Separated, Widowed 23.2 28.3 0.36
Education (%) Some post-secondary education 73.3 59.8 0.02 *
Employment Status (%) Employed 60.4 45.3 <0.01 **
Unemployed 5.0 3.1
Not in Labor Force 34.6 51.6
*Statistically signiﬁcant at p < 0.05.
**Statistically signiﬁcant at p < 0.01.
yResults can not be shown due to small numbers reporting.
Table 3
Association between antidepressant use in 1998/99 and depression in 2006/07
among 321 individuals with depression in 1998/99.
Effect of antidepressant use
on depression
eight years later OR (95% CI)
Unadjusted model 0.94 (0.44, 2.01)
Model adjusted for propensity quintiles 0.70 (0.30, 1.61)
Model adjusted for propensity
quintiles and antidepressant use
from 2000 to 2007
0.36 (0.15, 0.88)
Results in bold are signiﬁcant at p < 0.05.
I. Colman et al. / Journal of Psychiatric Research 45 (2011) 1012e1018 1015Adequate data were available on 321 individuals in order to
assess the presence of depression in 2006/07. In unadjusted
models, depressed individuals who reported antidepressant use
in 1998/99 were equally likely to have a major depressive
episode in 2006/07 as those who did not report antidepressant
use (OR ¼ 0.94, 95% CI: 0.44e2.01; see Table 3). Among those
using anti-depressants at baseline, 77.9% used anti-depressants
during the follow-up period between 2000 and 2007, while
33.0% of those who did not use anti-depressants at baseline
reported antidepressant use during the follow-up period. After
adjusting for propensity for antidepressant use in 1998/99, and
antidepressant use from 2000 to 2007 (see Table 2), depressed
individuals who received antidepressant use in 1998/99 were
less likely to be depressed in 2006/07 compared to those who
did not use anti-depressants (OR ¼ 0.36, 95% CI: 0.15e0.88).
Notably, recent antidepressant use was strongly and positively
associated with major depression in the model. The individuals
who reported antidepressant use during the previous six years
were much more likely to have major depression in 2006/07
(OR ¼ 5.83, 95% CI: 2.36e14.36).
In the comparison of antidepressant use, counseling by a health
profession and no treatment (see Table 4), those who used anti-
depressants at baseline were signiﬁcantly less likely to be
depressed eight years later (OR ¼ 0.32, 95% CI: 0.12e0.85)
compared to those who were not treated after adjusting for
propensity for treatment and use of anti-depressants during the
follow-up period. However, no differences in depression at follow-
up were noted between those who reported seeing a health
professional at baseline and thosewhowere not treated (OR¼ 0.93,
95% CI: 0.39e2.22).
4. Discussion
4.1. Highlights and related ﬁndings
Our results from a national Canadian cohort ﬁnd that depressed
individuals who reported antidepressant use in 1998/1999 were
less likely to display depressive symptoms eight years later.
Numerous randomized controlled trials have shown that antide-
pressant treatment is efﬁcacious for individuals suffering from
amajor depressive episode, particularly those suffering from severe
symptoms (Fournier et al., 2010). However, these trials often havestrict inclusion criteria that exclude patients with suicidal ideation
and comorbid illnesses, leaving trial subjects generally unrepre-
sentative of the patient population commonly seen in clinical
practice (Barbui and Hotopf, 2001; Leon et al., 2003). Observational
studies present an opportunity to demonstrate potential effec-
tiveness of anti-depressants in general populations, particularly if
they account for confounding by indication by using propensity-
for-treatment models. One notable study used a propensity score
analysis on observational data to study 285 depressed patients over
a 20-year period, and found individuals using higher levels of anti-
depressants were signiﬁcantly more likely to recover from symp-
toms in the short term (Leon et al., 2003). Given that there is little
data on long-term outcomes of antidepressant use (Rouillon, 2004),
another used propensity-for-treatment techniques to study 204
depressed members of a national British birth cohort, and found
that individuals using anti-depressants or anxiolytics were signif-
icantly less likely to be suffering from symptoms of depression ten
years later (Colman et al., 2008a), similar to the results observed
here in this Canadian sample.
Although maintenance use of anti-depressants after an initial
depressive episode has been shown to reduce the likelihood of
a relapse episode (Geddes et al., 2003), the majority of individuals
with depression do not continue antidepressant treatment in the
long term, even if they are suffering from chronic symptoms
(Bockting et al., 2008; Colman et al., 2008a). Consequently, our
positive results are unlikely to be explained by long-term use of
anti-depressants. In order to conﬁrm this, we controlled for anti-
depressant use during the follow-up period in our study to ensure
that antidepressant use at baseline was not just an indicator of
subsequent or ongoing use. There is currently little evidence to
Table 4
Association between depression in 2006/07 and antidepressant use or counseling by a health professional in 1998/99 (compared to no treatment)
among 321 individuals with depression in 1998/99.
Effect of antidepressant use on depression
eight years later OR (95% CI)
Effect of counseling by
a health professional on depression
eight years later OR (95% CI)
Unadjusted model 1.13 (0.48, 2.68) 1.61 (0.72, 3.60)
Model adjusted for propensity quintiles 0.58 (0.24, 1.38) 0.97 (0.44, 2.16)
Model adjusted for propensity quintiles and
antidepressant use from 2000 to 2007
0.32 (0.12, 0.85) 0.93 (0.39, 2.22)
Results in bold are signiﬁcant at p < 0.05.
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hippocampus, that are inﬂuenced by antidepressant use continue
after withdrawal of the medication (DeRubeis et al., 2008).
Consequently, the effects observed in our study appear point to the
importance of receiving initial treatment that maximizes the like-
lihood of complete remission of symptoms. Periods of partial
remission are relatively common after treatment (Cornwall and
Scott, 1997), and have been associated with increased hopeless-
ness, suicide, life dissatisfaction, and decreased psychosocial func-
tioning (Viinamaki et al., 2008). During periods of partial remission,
these symptoms often go untreated (Cornwall and Scott, 1997) and
are associated with signiﬁcantly higher rates of relapse episodes of
depression (Pintor et al., 2003).
The association observed in this study between baseline anti-
depressant use and reduced risk of depression eight years latermay
be a reﬂection of treatment-seeking behavior rather than an effect
of treatment with anti-depressants. Perceived need for treatment
and treatment-seeking behavior were not measured in our study
but are strongly associatedwith treatment for depression (Mojtabai
et al., 2002). Those who have a positive attitude toward mental
health treatment are more likely to pursue treatment when
suffering from symptoms of mental illness (Mojtabai et al., 2002).
We were not able to measure perceived need for treatment, atti-
tudes toward mental health treatment or treatment-seeking
behavior in our study; however, it may be that those who report
being treated for depression at baseline are more likely to perceive
a need for treatment and seek treatment during subsequent
episodes (Colman et al., 2008a).
Notably, our study found that reported antidepressant use
during the follow-up period was associated with a poor outcome.
This is likely due to the selection factors that led us to use
propensity score techniques in our analysis of baseline antide-
pressant use. In other words, it is likely that those who report
antidepressant use during the follow-up period are suffering from
more severe symptoms and are likely to have a poor outcome at the
end of the follow-up period. However, after adjusting for this, we
ﬁnd that those who reported antidepressant use during their initial
episode had a better long-term outcome. This suggests that the
longer depressive symptoms persist before treatment the worse
the long-term prognosis may be. Supporting this concept is
evidence from other studies that have shown individuals who have
had a longer duration of depressive symptoms before treatment are
more likely to have relapse episodes during several years of follow-
up (Kennedy et al., 2003; Mueller et al., 1999).
4.2. Strengths and limitations
It is not possible to make inferences about causality based on
our study. Randomized controlled trials provide much stronger
evidence for causality, particularly with large samples, as the
randomization process ensures that the groups are comparable on
all factors. Although our propensity-for-treatment model balanced
several key determinants of antidepressant use, there are manyother factors that were not measured in this study that could also
be associated with both treatment and prognosis. An important
additional unmeasured factor that could be associated with both
treatment and prognosis is common comorbid psychiatric illness
such as generalized anxiety disorder. The NPHS does not assess
anxiety disorders. The inclusion of the distress scale, which
includes nervousness and restlessness, should have captured some
of the comorbidity introduced by anxiety disorders, but not all.
However, those with comorbid disorders are more likely to seek
treatment (Andrews et al., 2001; Mojtabai et al., 2002; Spijker et al.,
2001) and more likely to have a poor prognosis (Ormel et al., 1993).
Not accounting for this in our design biases our results toward the
null, suggesting that the presented results are conservative.
This study did not have sufﬁcient data to assess long-term
outcomes associated with evidence-based psychotherapy inter-
ventions for depression. We attempted a crude measurement of
possible exposure to psychotherapy through contact to a health
professional, but datawere not available to assess what, if any, non-
pharmaceutical treatment might have been offered by the health
professional. Nevertheless, there is strong evidence supporting
long-term prevention of depression for non-pharmaceutical treat-
ments. In particular, cognitive behavioral therapy has been shown
to prevent relapse of depressive symptoms over several years after
the initial episode (Bockting et al., 2009; Fava et al., 2004), by
changing the way individuals who have had a depressive episode
process depression-related material from an absolutist view to
a relativist view (Teasdale et al., 2001). There is some evidence to
suggest that cognitive behavioral therapy is as or more effective
than medication in preventing recurrence of symptoms over the
long term (Hollon et al., 2005). Other non-pharmaceutical treat-
ments may have similar long-term prevention effects. For example,
a recent review showed that community-based social support
(“befriending”) has a signiﬁcant long-term effect on reduction of
depressive symptoms (Mead et al., 2010). Nevertheless, such
patients would have been included in our untreated group and
therefore bias our results toward a more conservative ﬁnding.
Another limitation is that we do not consider long-term side
effects that may be associated with antidepressant use. For
example, the use of selective serotonin reuptake inhibitors (SSRI)
has been associated with many long-term side effects including
osteoporosis, cardiovascular side effects, and alopecia (Moret et al.,
2009). In addition, SSRI use has been associated with an increased
risk of suicidal behavior in adolescents (Barbui et al., 2009).
This study used the CIDI short form instead of the full CIDI.
Although the CIDI-SF has a 93% classiﬁcation accuracy for a major
depressive episode compared with the full CIDI (Kessler et al., 1998),
individuals could have beenmisclassiﬁedwith respect to the primary
outcome. Such non-differential misclassiﬁcation biases results
toward the null, suggesting the results we present are conservative.
Finally, this study, as with any longitudinal study, did not have
complete data on all individuals at the eight-year follow-up point.
Those without follow-up data were no different from those with
follow-up data with regards to their CIDI-SF score; however, they
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scores on the distress scale, suggesting they may have had a higher
degree of severity and consequently a poorer prognosis. There was
no difference between these two groups with respect to antide-
pressant use at baseline, so any effects of higher severity patients
being lost does not appear to be differential with respect to anti-
depressant use and consequently is unlikely to bias the association
between antidepressant use and subsequent depression.
The limitations to this study are outweighed by several strengths.
The sample for this study was a large population-based sample.
Population-based samples are particularly helpful as the results
obtained from such samples are relevant to the general population,
not just the small group that meet inclusion criteria for antidepres-
sant RCTs (Barbui andHotopf, 2001; Leon et al., 2003). This study is of
particular value in that data on a variety of factors that are associated
with depression treatment and prognosis were available including
information on antidepressant use throughout the follow-up period.
We conﬁrm the ﬁndings of an earlier British study, which used an
age-homogenous sample, combined anxiolytics with anti-depres-
sants, and used a general screen for symptoms of depression and
anxiety to show long-term positive outcomes associated with
psychotropic medication use (Colman et al., 2008a). However, this
Canadian sample provided adults of all ages, studied currently
prescribed anti-depressants, and used a structured assessment for
depression which has been widely used for epidemiological studies
and conforms to widely used diagnostic criteria (Kessler et al., 1998).
These strengths underscore the provocative ﬁndings, which suggest
that treatment for major depression may have signiﬁcant long-term
beneﬁts.
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